| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041946288 |
| P356 | DOI | 10.1038/APS.2012.83 |
| P932 | PMC publication ID | 4002710 |
| P698 | PubMed publication ID | 22902986 |
| P5875 | ResearchGate publication ID | 230697907 |
| P2093 | author name string | Ying Xue | |
| Jian-Ming Hou | |||
| Qing-Ming Lin | |||
| P2860 | cites work | Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo | Q24294453 |
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Runx2: a master organizer of gene transcription in developing and maturing osteoblasts | Q28274182 | ||
| Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women | Q28307740 | ||
| The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells | Q28580727 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Osteoclast differentiation and activation | Q29547556 | ||
| Lactoferrin--a novel bone growth factor | Q33218791 | ||
| Relationship of bone turnover to bone density and fractures | Q34430413 | ||
| Multifunctional roles of lactoferrin: a critical overview | Q34464216 | ||
| Osteoimmunology | Q36693328 | ||
| Transcription factors controlling osteoblastogenesis | Q37106754 | ||
| Twenty-five years of research on bovine lactoferrin applications | Q37201798 | ||
| Current and emerging therapies for osteoporosis. | Q37613807 | ||
| Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization | Q40327271 | ||
| Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis | Q40565765 | ||
| Lactoferrin: molecular structure and biological function | Q40926159 | ||
| Defective bone remodelling in osteoprotegerin-deficient mice | Q44751176 | ||
| Oral bovine lactoferrin improves bone status of ovariectomized mice. | Q51646877 | ||
| Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats. | Q51648275 | ||
| Effect of lactoferrin-embedded collagen membrane on osteogenic differentiation of human osteoblast-like cells. | Q51821276 | ||
| Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins | Q70710358 | ||
| The effect of ovariectomy on bone metabolism in rats | Q70947099 | ||
| Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity | Q74577370 | ||
| Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway | Q83226947 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microstructure | Q1498213 |
| P304 | page(s) | 1277-1284 | |
| P577 | publication date | 2012-08-20 | |
| P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
| P1476 | title | Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway | |
| P478 | volume | 33 |
| Q38643354 | Alendronate Functionalized Mesoporous Bioactive Glass Nanospheres. |
| Q35110124 | Antiosteoporosis Activity of New Oriental Medicine Preparation (Kyungokgo Mixed with Water Extract of Hovenia dulcis) on the Ovariectomized Mice |
| Q35689317 | Bone Regeneration Is Promoted by Orally Administered Bovine Lactoferrin in a Rabbit Tibial Distraction Osteogenesis Model |
| Q37653861 | Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss |
| Q35684335 | Coupling Hydroxyapatite Nanocrystals with Lactoferrin as a Promising Strategy to Fine Regulate Bone Homeostasis |
| Q33582576 | Dioscin promotes osteoblastic proliferation and differentiation via Lrp5 and ER pathway in mouse and human osteoblast-like cell lines |
| Q38412968 | Effects of in ovo injection of bovine lactoferrin before incubation in layer breeder eggs on tibia measurements and performance of laying hens |
| Q96231641 | Hepcidin deficiency causes bone loss through interfering with the canonical Wnt/β-catenin pathway via Forkhead box O3a |
| Q57812844 | Influence of Iron on Bone Homeostasis |
| Q35935497 | Lactoferrin Induces Osteoblast Growth through IGF-1R. |
| Q46256576 | Lactoferrin in a Context of Inflammation-Induced Pathology |
| Q36745179 | Lactoferrin inhibits apoptosis through insulin-like growth factor I in primary rat osteoblasts |
| Q56516677 | Lactoferrin promote primary rat osteoblast proliferation and differentiation via up-regulation of insulin-like growth factor-1 expression |
| Q50135768 | Local application of lactoferrin promotes bone regeneration in a rat critical-sized calvarial defect model as demonstrated by micro-CT and histological analysis. |
| Q28551480 | Multi-Scale Agent-Based Multiple Myeloma Cancer Modeling and the Related Study of the Balance between Osteoclasts and Osteoblasts |
| Q33794181 | The osteogenesis-promoting effects of alpha-lipoic acid against glucocorticoid-induced osteoporosis through the NOX4, NF-kappaB, JNK and PI3K/AKT pathways |
Search more.